Cargando…

Latest insights in disease-modifying osteoarthritis drugs development

Osteoarthritis (OA) is a prevalent and severely debilitating disease with an unmet medical need. In order to alleviate OA symptoms or prevent structural progression of OA, new drugs, particularly disease-modifying osteoarthritis drugs (DMOADs), are required. Several drugs have been reported to atten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shengfa, Cao, Peihua, Chen, Tianyu, Ding, Changhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Addressing the Challenges Associated with the Development, Testing and Approval of Novel Therapeutics for Osteoarthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184265/ https://www.ncbi.nlm.nih.gov/pubmed/37197024 http://dx.doi.org/10.1177/1759720X231169839

Ejemplares similares

Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022)

Latest advancements in imaging techniques in OA
por: Hayashi, Daichi, et al.
Publicado: (2022)

The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities
por: Kim, Heungdeok, et al.
Publicado: (2022)

Regenerative medicine for early osteoarthritis
por: Im, Gun-Il, et al.
Publicado: (2023)

Emerging molecular biomarkers in osteoarthritis pathology
por: Sandhu, Amit, et al.
Publicado: (2023)

Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort
por: Ali, Shabana Amanda, et al.
Publicado: (2022)

Comparative validation of the knee inflammation MRI scoring system and the MRI osteoarthritis knee score for semi-quantitative assessment of bone marrow lesions and synovitis-effusion in osteoarthritis: an international multi-reader exercise
por: Maksymowych, Walter P., et al.
Publicado: (2023)

Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
por: Meng, Fanqiang, et al.
Publicado: (2022)

Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis
por: Martel-Pelletier, Johanne, et al.
Publicado: (2023)

Comparison of clinical efficiency between intra-articular injection of platelet-rich plasma and hyaluronic acid for osteoarthritis: a meta-analysis of randomized controlled trials
por: Chen, Lili, et al.
Publicado: (2023)

Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials
por: Zhao, Di, et al.
Publicado: (2022)

Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression
por: Guermazi, Ali, et al.
Publicado: (2023)

Evaluation of local tissue peri-implant reaction in total knee arthroplasty failure cases
por: Brozovich, Ava, et al.
Publicado: (2022)

Early knee OA definition–what do we know at this stage? An imaging perspective
por: Li, Xiaojuan, et al.
Publicado: (2023)

Role of imaging for eligibility and safety of a-NGF clinical trials
por: Roemer, Frank W., et al.
Publicado: (2023)

Quantitative infrapatellar fat pad signal intensity alteration as an imaging biomarker of knee osteoarthritis progression
por: Cen, Han, et al.
Publicado: (2023)

Insights into osteoarthritis development from single-cell RNA sequencing of subchondral bone
por: Shen, Ping, et al.
Publicado: (2022)

CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene
por: Shen, Shuying, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
por: Zhu, Hongyi, et al.
Publicado: (2023)

Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse model
por: Julovi, Sohel M, et al.
Publicado: (2023)

The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis – A comparative study with data from Osteoarthritis Initiative
por: Li, Mingyang, et al.
Publicado: (2021)

Association between hyperuricaemia and hand osteoarthritis: data from the Xiangya Osteoarthritis Study
por: Zhu, Yanqiu, et al.
Publicado: (2023)

Magnetic Resonance Imaging–Defined Osteoarthritis Features and Anterior Knee Pain in Individuals With, or at Risk for, Knee Osteoarthritis: A Multicenter Study on Osteoarthritis
por: Macri, Erin M., et al.
Publicado: (2022)

Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis
por: Haugen, Ida K, et al.
Publicado: (2020)

Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: data from the Osteoarthritis Initiative
por: Camacho-Encina, María, et al.
Publicado: (2019)

Average symptom trajectories following incident radiographic knee osteoarthritis: data from the Osteoarthritis Initiative
por: Whittle, Rebecca, et al.
Publicado: (2016)

Association Between Gut Microbiota and Symptomatic Hand Osteoarthritis: Data From the Xiangya Osteoarthritis Study
por: Wei, Jie, et al.
Publicado: (2021)

Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative
por: Bowes, Michael A., et al.
Publicado: (2021)

Structural Associations of Symptomatic Knee Osteoarthritis
por: Stoppiello, Laura A, et al.
Publicado: (2014)

Obesity, osteoarthritis and genetic risk: The rs182052 polymorphism in the ADIPOQ gene is potentially associated with risk of knee osteoarthritis
por: Jiang, L., et al.
Publicado: (2018)

Towards secondary prevention of early knee osteoarthritis
por: Mahmoudian, Armaghan, et al.
Publicado: (2018)

Critical role for arginase II in osteoarthritis pathogenesis
por: Choi, Wan-Su, et al.
Publicado: (2019)

Diabetes mellitus is not a risk factor for osteoarthritis
por: Khor, Andrew, et al.
Publicado: (2020)

Increased risk of osteoarthritis in patients with atopic disease
por: Baker, Matthew C, et al.
Publicado: (2023)

Genome-wide association of phenotypes based on clustering patterns of hand osteoarthritis identify WNT9A as novel osteoarthritis gene
por: Boer, Cindy Germaine, et al.
Publicado: (2021)

Pain in hand osteoarthritis is associated with crystals in the synovial fluid: a cross-sectional study of people with hand osteoarthritis undergoing surgery
por: Døssing, Anna, et al.
Publicado: (2023)

Willingness to Undergo Joint Surgery Following a First‐Line Intervention for Osteoarthritis: Data From the Better Management of People With Osteoarthritis Register
por: Dell’Isola, Andrea, et al.
Publicado: (2021)

Translation of clinical problems in osteoarthritis into pathophysiological research goals
por: van der Kraan, Peter M, et al.
Publicado: (2016)

Characterization of the Cartilage DNA Methylome in Knee and Hip Osteoarthritis
por: Rushton, Michael D, et al.
Publicado: (2014)

Genomic Risk Score for Advanced Osteoarthritis in Older Adults
por: Lacaze, Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n2gat41mjbierlm536nlvtdsv5